A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...
A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...
Informed and shared decision-making is essential in lung cancer treatment, emphasizing clinical trial participation for advancing therapies. CheckMate 816 study showed improved overall survival with ...
A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference. The model, called ...
Please provide your email address to receive an email when new articles are posted on . Most Medicare beneficiaries did not have a shared decision-making (SDM) visit before their first lung cancer ...
Please provide your email address to receive an email when new articles are posted on . Many patients with lung cancer and their caregivers reported they lacked involvement in decision-making. Complex ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2) — A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance.
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback